Literature DB >> 25879290

Hepatitis regulation by the inflammasome signaling pathway.

Amina A Negash1, Michael Gale.   

Abstract

Hepatitis is damage and inflammation of the liver. It is triggered by both environmental and endogenous insults and is a platform for developing liver cirrhosis and cancer. Both innate and adaptive immune activation contribute to hepatic inflammation and disease. Viral hepatitis is the most common form of hepatitis and is typically associated with chronic viral infection. Alcohol-induced and non-alcoholic steatohepatitis are two rising hepatic problems. The innate immune inflammasome signaling cascade mediates the production of essential proinflammatory cytokines interleukin-1β (IL-1β) and IL-18. These cytokines regulate hepatic cell interaction and crosstalk of the various inflammatory pathways and influence disease outcome.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-1β and IL-18; hepatitis; inflammasomes; inflammation; innate immunity; proinflammatory cytokines

Mesh:

Substances:

Year:  2015        PMID: 25879290     DOI: 10.1111/imr.12279

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  16 in total

1.  The inflammasome: firing up innate immunity.

Authors:  Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

2.  Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.

Authors:  Akiko Eguchi; Raul G Lazaro; Jiaohong Wang; Jihoon Kim; Davide Povero; Brandon Willliams; Samuel B Ho; Peter Stärkel; Bernd Schnabl; Lucila Ohno-Machado; Hidekazu Tsukamoto; Ariel E Feldstein
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

3.  Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.

Authors:  Geoffrey J Markowitz; Pengyuan Yang; Jing Fu; Gregory A Michelotti; Rui Chen; Jianhua Sui; Bin Yang; Wen-Hao Qin; Zheng Zhang; Fu-Sheng Wang; Anna Mae Diehl; Qi-Jing Li; Hongyang Wang; Xiao-Fan Wang
Journal:  Cancer Res       Date:  2016-02-18       Impact factor: 12.701

4.  The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage.

Authors:  Chiara Rossi; Antonio Salvati; Mariarosaria Distaso; Daniela Campani; Francesco Raggi; Edoardo Biancalana; Domenico Tricò; Maurizia Rossana Brunetto; Anna Solini
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 5.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

6.  Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma.

Authors:  Myoung Sook Han; Tamera Barrett; Michael A Brehm; Roger J Davis
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

Review 7.  Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease.

Authors:  Xiaoqin Wu; Lei Dong; Xianhe Lin; Jun Li
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

Review 8.  The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties.

Authors:  Jinghua Peng
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

Review 9.  Interleukin-1 Family Cytokines in Liver Diseases.

Authors:  Hiroko Tsutsui; Xianbin Cai; Shuhei Hayashi
Journal:  Mediators Inflamm       Date:  2015-10-15       Impact factor: 4.711

Review 10.  The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review.

Authors:  Marco Rossato; Angelo Di Vincenzo; Claudio Pagano; Hamza El Hadi; Roberto Vettor
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.